エピソード

  • The Drugstore Cowboy Rides Again: PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients | TWIRx

    The Drugstore Cowboy Rides Again: PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients | TWIRx
    2025/11/07

    This Week in Pharmacy - November 7, 2025

    TWIRx News: First up, Binghamton University School of Pharmacy holds emergency management simulation, VCU Health pharmacies expand access through new home delivery options, and Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans.

    Our special guest line up on TWIRx:

    • Amantha Bagdon - CEO of RxPost
    • PGX Pharmacist's Protection of Patients with Dr. Melissa Smith PharmD
    • Arkansas HB 1150 TO PROHIBIT A PHARMACY BENEFITS MANAGER FROM OBTAINING CERTAIN PHARMACY PERMITS. with John Vinson CEO of the Arkansas Pharmacy Association & Greg Reybold with APCI
    • 4th Generation Pharmacy Owner C.O. Bigelow (the oldest Apothecary in America) the Drugstore Cowboy, Alec Gingsberg PharmD

    Thank you toour sponsors:

    • Independent Pharmacy Cooperative (IPC)
    • Yaral Pharma
    • SureCost

    The Drugstore Cowboy Rides Again: PBM Reform in Arkansas & PGx Safeguards for Xeloda Patients | TWIRx
    続きを読む 一部表示
    1 時間 46 分
  • OvaryIt: Breaking Barriers to Birth Control with Pharmacists at the Center | MaternalRx

    OvaryIt: Breaking Barriers to Birth Control with Pharmacists at the Center | MaternalRx
    2025/11/06
    On this episode of MaternalRx on the Pharmacy Podcast Network, host Dr. Danielle Raiman Plummer, PharmD, consulting pharmacist, sits down with Mary Kucek, PMP, and Dr. Devin Bustin, MD, co-founders of OvaryIt, creators of the PRISM EHR platform and the OvaryIt Foundation for survivors of domestic abuse and human trafficking. Mary shares her powerful and life-threatening experience with a telemedicine platform that failed to follow contraceptive safety guidelines, an event that changed the course of her career and mission. Together, Mary and Dr. Bustin explain how their NIH-funded research led to the creation of OvaryIt and PRISM: an innovative, pharmacist-centered platform that bridges the safety of in-person care with the accessibility of telehealth. Tune in to hear how retail pharmacists can now lead the next evolution in family planning access, overcoming the barriers to scaling these services, and how technology and policy can empower safer, more equitable reproductive care for all. “Prism will help retail pharmacies become public health access points for central health services.” 💡 Stay Connected & Take Action! - Follow OvaryIt on all social platforms to stay updated on their mission to expand safe, pharmacist-led access to reproductive care. - For Patients: Learn more or find care at MyPrismHealth.com. - For Pharmacists, Pharmacy Owners, and Staff: Discover how to bring contraceptive care to your community with GetPrismRx.com. - Explore Free Education & Advocacy: Visit OvaryFund.org — the OvaryIt Foundation supporting survivors of domestic abuse and human trafficking through education and access. - Advocate for Change: Contact your local representatives to support the ECAPS Act, which recognizes pharmacists as healthcare providers under Medicare Part B and helps expand access to essential reproductive health services. Disclaimer: This podcast is for educational purposes only and should not replace medical advice. 🎧 Listen now to MaternalRx, redefining maternal health, from preconception through postpartum.
    続きを読む 一部表示
    45 分
  • Preventable Toxicity: The Pharmacogenomics Case for DPYD Testing in Oncology | Precision Medicine Pharmacist Podcast

    Preventable Toxicity: The Pharmacogenomics Case for DPYD Testing in Oncology | Precision Medicine Pharmacist Podcast
    2025/11/05
    Fluoropyrimidines such as 5-fluorouracil (5-FU) and capecitabine remain cornerstone chemotherapies in oncology. However, for patients with certain DPYD gene variants, these commonly used drugs can cause life-threatening toxicities due to impaired metabolism of the active compounds. In this episode of the Precision Medicine Pharmacist Podcast, host Melissa Smith, PharmD, explores how DPYD genotyping is transforming oncology care by helping clinicians identify patients at risk before toxicity occurs. Joined by Karen Merritt, an advocate for universal DPD testing and leader with the Test4DPD initiative, the discussion sheds light on how pharmacogenomics is shaping safer, more personalized cancer treatment. Together, they explore current evidence, new FDA updates, and implementation frameworks that empower pharmacists and oncology teams to prevent preventable harm through precision medicine. 🧠 Key Discussion Topics
    • The science behind DPYD gene variants and their clinical implications
    • How undiagnosed DPD deficiency contributes to preventable toxicity
    • New recommendations from the CPIC® Guideline for Fluoropyrimidines and DPYD
    • Insights from the Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines
    • Advocacy for universal DPYD testing across oncology centers
    • How pharmacists can champion pharmacogenomic testing integration in oncology workflows
    • Updates from the FDA-approved labeling for Xeloda (capecitabine)
    🎧 Featured Guest Karen Merritt LinkedIn Profile Karen Merritt is a passionate advocate for pharmacogenomic testing and patient safety in oncology care. Through her leadership in the Test4DPD movement, she works to expand awareness and adoption of DPYD testing worldwide, ensuring patients are protected from severe chemotherapy-related toxicities. 📚 Resources & References
    • Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice (PMC)
    • CPIC® Guideline for Fluoropyrimidines and DPYD
    • Advocates for Universal DPD/DPYD Testing – Test4DPD
    • Updated FDA-Approved Label for Xeloda (Capecitabine)
    💊 About the Show The Precision Medicine Pharmacist Podcast explores the evolving role of pharmacists in precision health, pharmacogenomics, and individualized patient care. Each episode highlights clinical insights, implementation strategies, and inspiring stories from professionals leading the way in personalized medicine.
    続きを読む 一部表示
    39 分
  • Inside M3P: What Medicare Providers and Patients Need to Know | NASP Specialty Pharmacy Podcast

    Inside M3P: What Medicare Providers and Patients Need to Know | NASP Specialty Pharmacy Podcast
    2025/11/04

    During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Sheri Wallace, Account Representative at AcariaHealth Specialty Pharmacy, and Diane Omdahl, RN, MS, founder of 65 Incorporated, published author and consultant on Medicare, to unpack the complexities of the Medicare Prescription Payment Plan (MPPP). Drawing on decades of patient access experience and the finer points of Medicare, they share insights on how these changes impact patients, providers, and pharmacies alike. Learn the importance of education, transparency, and advocacy in ensuring patients don’t fall through the cracks during these changes. Whether you're a provider, pharma partner, or patient advocate, this episode offers practical guidance and expert perspectives to help you navigate the evolving Medicare landscape.
    続きを読む 一部表示
    44 分
  • Xplore: Growth, Technology, Connections, and Solutions | PrimeRx User Conference Part One

    Xplore: Growth, Technology, Connections, and Solutions | PrimeRx User Conference Part One
    2025/11/03

    The Pharmacy Podcast Network attended Xplore 2025, PrimeRx's Inaugural User Conference, capturing the voices of independent pharmacy owners, students, and industry leaders. In this episode, Todd Eury talks with:

    Ashton Maaraba with IPC iCare+

    Leo Gjoni with DrugLift

    Ayah Elzibak, Pharmacy Student

    Will Tuft with RxSafe Eyecon
    続きを読む 一部表示
    34 分
  • Data to Impact: Nested Knowledge & the 31-Day Pharmacist Challenge | TWIRx

    Data to Impact: Nested Knowledge & the 31-Day Pharmacist Challenge | TWIRx
    2025/10/31
    TWIRx in the WORKS!!! Welcome back to This Week in Pharmacy (TWIRx) — your weekly deep dive into the most important pharmacy news, innovations, and conversations shaping healthcare. In this episode, host Todd Eury brings you stories that move from data to impact, exploring how pharmacists are driving change through knowledge, leadership, and advocacy. 🗞️ TWIRx News Roundup Wrapping up IDWeek 2025 with the latest insights from Pharmacy Practice News and more breaking updates across the profession:

    💊 How Well Are You Using Fetroja? Understanding appropriate use of cefiderocol and antibiotic resistance challenges. 🔗 Read at Pharmacy Practice News

    ⚕️ AFPs Affect Access to Specialty Medications Learn how alternative funding programs are impacting patient access and specialty care. 🔗 Read at Specialty Pharmacy Continuum

    🚨 FDA Recall Alert Drug makers recall a blood pressure medicine tainted with a cancer-causing chemical. 🔗 Read the full story via AP News

    🧠 Meeting Patients Where They Are How pharmacists are supporting patients managing schizophrenia treatment adherence. 🔗 Read at Pharmacy Times

    🎤 Featured Guest: Keith Kallmes President, Nested Knowledge A deep conversation on how Nested Knowledge is transforming the way clinical data becomes actionable insights for healthcare decision-makers. Connect with Keith on LinkedIn 🧬 Today’s TWIRx is sponsored by Nested Knowledge — advancing research automation and evidence synthesis to accelerate medical innovation. 💪 31-Day Pharmacist Challenge A huge thank you to Dr. Jesse McCullough, PharmD — Founder of Keystone Pharmacy Insights — for inspiring the pharmacy community through the 31-Day Pharmacist Challenge during Pharmacist Month! Connect with Jesse on LinkedIn Join his Leadership Community for Pharmacists on SKOOL 🔥 Bonus Guest: Matthew Zachary Principal, Matthew Zachary Worldwide The outspoken healthcare advocate returns to rage against the PBM Mafia, shining a light on the broken business models of the “Big 3” PBMs. Shout-out to Mark Cuban Cost Plus Drugs for disrupting the system and fighting for transparency and affordability for patients everywhere. 📢 Subscribe & Connect Stay tuned to This Week in Pharmacy (TWIRx) for the most relevant stories, data insights, and voices advancing the future of pharmacy care. Follow the Pharmacy Podcast Network on: 🌐 PharmacyPodcast.com 🔗 LinkedIn | X | YouTube | Spotify | Apple Podcasts Data to Impact: Nested Knowledge & the 31-Day Pharmacist Challenge | TWIRx
    続きを読む 一部表示
    55 分
  • Lies and Lawsuits | Essential: The Pharmacy Compounding Podcast

    Lies and Lawsuits | Essential: The Pharmacy Compounding Podcast
    2025/10/30
    In this edition of Essential, we look at how we’re pushing back against the FDA’s upcoming ban on desiccated thyroid extract, why drugmakers’ latest tactics against compounding pharmacies are backfiring, and we give you a great way to make sure your practice is performing at its best. Then we take a deep dive with attorney and pharmacist Mark Boesen into the lawsuits being filed against compounding pharmacies, what the results have been, and how they might affect more than just pharmacy in the future. Boesen & Snow Law: https://www.boesensnowlaw.com/ DTE story (https://a4pc.org/news/ask-your-patients-help-us-protect-dte-access) “FDA’s confusing warning letters” (https://a4pc.org/news/fdas-confusing-warning-letters) “FDA’s green list: Not our problem?” (https://a4pc.org/news/fdas-green-list-not-our-problem) Compounding.com/thyroid Best practices documents (a4pc.org/bestpractices) National Review article on FDA crackdown (https://archive.ph/LYy7t)
    続きを読む 一部表示
    42 分
  • NSAIDs: Everything and Then Some | Pain Pod

    NSAIDs: Everything and Then Some | Pain Pod
    2025/10/29

    NSAIDs are everywhere, prescription, OTC, topical, oral, injectable, you name it! In an era of Opioidphobia, are they really a panacea? Heck no, all medications come with baggage. We could spend hours talking about NSAIDs, and not even get to the elephant in the room: Which NSAID for Which Patient? So we’ll go there in this succinct, yet comprehensive rapid review of all things NSAIDs on the Pain Pod! Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us
    続きを読む 一部表示
    38 分